
MediLumine
B2B
research
Website
medilumine.comFounded
2013
Employees
1-10
Revenue
0-1m
Headquarters
Montreal, Canada
About
MediLumine is committed to providing high quality instruments, reagents and accessories to support preclinical imaging programs in the life sciences. MediLumine's PRISM™ series of in vivo imaging systems are designed for preclinical monitoring of physiological changes in living systems for therapeutic discovery research in universities and pharmaceutical companies. MediLumine's Fenestra® and Mvivo™ contrast agents for micro-CT Imaging provide image enhancement for various applications allowing scientists to monitor progression of functional liver diseases, quantify tumor burdens, track cells in vivo and perform preclinical angiography.
Sell to MediLumine
Connect with MediLumine directly.